Joint NOD2/RIPK2 Signaling Regulates IL-17 Axis and Contributes to the Development of Experimental Arthritis


Autoria(s): Vieira, Silvio M.; Cunha, Thiago M.; Franca, Rafael F. O.; Pinto, Larissa G.; Talbot, Jhimmy; Turato, Walter M.; Lemos, Henrique P.; Lima, Jonilson B.; Verri, Waldiceu A., Jr.; Almeida, Sergio C. L.; Ferreira, Sergio H.; Louzada-Junior, Paulo; Zamboni, Dario S.; Cunha, Fernando Q.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

04/11/2013

04/11/2013

2012

Resumo

Intracellular pattern recognition receptors such as the nucleotide-binding oligomerization domain (NOD)-like receptors family members are key for innate immune recognition of microbial infection and may play important roles in the development of inflammatory diseases, including rheumatic diseases. In this study, we evaluated the role of NOD1 and NOD2 on development of experimental arthritis. Ag-induced arthritis was generated in wild-type, NOD1(-/-)!, NOD2(-/-), or receptor-interacting serine-threonine kinase 2(-/-) (RIPK2(-/-)) immunized mice challenged intra-articularly with methylated BSA. Nociception was determined by electronic Von Frey test. Neutrophil recruitment and histopathological analysis of proteoglycan lost was evaluated in inflamed joints. Joint levels of inflammatory cytokine/chemokine were measured by ELISA. Cytokine (IL-6 and IL-23) and NOD2 expressions were determined in mice synovial tissue by RT-PCR. The NOD2(-/-) and RIPK2(-/-), but not NOD1(-/-), mice are protected from Ag-induced arthritis, which was characterized by a reduction in neutrophil recruitment, nociception, and cartilage degradation. NOD2/RIPK2 signaling impairment was associated with a reduction in proinflammatory cytokines and chemokines (TNF, IL-1 beta, and CXCL1/KC). IL-17 and IL-17 triggering cytokines (IL-6 and IL-23) were also reduced in the joint, but there is no difference in the percentage of CD4(+) IL-17(+) cells in the lymph node between arthritic wild-type and NOD2(-/-) mice. Altogether, these findings point to a pivotal role of the NOD2/RIPK2 signaling in the onset of experimental arthritis by triggering an IL-17-dependent joint immune response. Therefore, we could propose that NOD2 signaling is a target for the development of new therapies for the control of rheumatoid arthritis. The Journal of Immunology, 2012, 188: 5116-5122.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)

Fundacao de Amparo a Pesquisa do Estado do Amazonas (Brazil)

Fundacao de Amparo a Pesquisa do Estado do Amazonas (Brazil)

Conselho Nacional de Pesquisa (Brazil)

Conselho Nacional de Pesquisa (Brazil)

Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)

Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)

Fundacao de Amparo a Pesquisa do Estado do Amazonas

Fundacao de Amparo a Pesquisa do Estado do Amazonas

Identificador

JOURNAL OF IMMUNOLOGY, BETHESDA, v. 188, n. 10, supl. 1, Part 3, pp. 5116-5122, MAY 15, 2012

0022-1767

http://www.producao.usp.br/handle/BDPI/40843

10.4049/jimmunol.1004190

http://dx.doi.org/10.4049/jimmunol.1004190

Idioma(s)

eng

Publicador

AMER ASSOC IMMUNOLOGISTS

BETHESDA

Relação

JOURNAL OF IMMUNOLOGY

Direitos

restrictedAccess

Copyright AMER ASSOC IMMUNOLOGISTS

Palavras-Chave #ANTIGEN-INDUCED ARTHRITIS #OLIGOMERIZATION DOMAIN 2 #NF-KAPPA-B #CASPASE RECRUITMENT DOMAIN #INNATE IMMUNE-RESPONSES #RHEUMATOID-ARTHRITIS #SYNOVIAL FIBROBLASTS #MURAMYL DIPEPTIDE #MICE DEFICIENT #MURINE MODEL #IMMUNOLOGY
Tipo

article

original article

publishedVersion